Advertisement

Related Videos

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Issues in Oncology
Cost of Care

The ASCO Post Staff

Mark J. Ratain, MD, and Daniel Goldstein, MD, on Value in Cancer Care: How the Paradigm Is Shifting

Mark J. Ratain, MD, of the University of Chicago, and Daniel Goldstein, MD, of the Rabin Medical Center, discuss the challenges of achieving cancer care value, evolution of the “more-is-better” philosophy when it comes to oncology drugs, and highlights of the First International Summit on Interventional Pharmacoeconomics.

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement




Aug
31
Today In Oncology
How to Adapt to the Era of AI and the Changing Interactions With Patients: Lessons From a Low-Resource Setting
Subspecialization in Oncology Is Increasing—But Unevenly Distributed Across the Country
Identifying CNS Tumors With Multianalyte Cerebrospinal Fluid Test
Adding Dendritic Cell Vaccination to Hepatocellular Carcinoma Therapy
Real-World Incidence and Management of Infusion-Related Reactions to Monoclonal Antibody Therapy
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo